Haematology and Oncology Archives - Page 3 of 19

Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits

Arturo Cuomo

Article Type

Review

Published

14 Dec 2023

This review provides an update on the management of breakthrough cancer pain with fentanyl, with consideration of safety, as it remains an important tool in the treatment of cancer pain.

Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases

Jonathan Wadsley, Alan Christie, Roopinder Gillmore, Amy Trinh, Rachel Greig

Article Type

Case Series

Published

14 Aug 2023

Three clinical cases are presented in this article to illustrate the position of pemigatinib in the management of cholangiocarcinoma and related toxicities.

Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors

Darren MC Poon, Kuen Chan, Angus Kwong-Chuen Leung, Brian Ng, Foon-Yiu Cheung, Steven Wai-Kwan Siu, Hong Kong Society of Uro-Oncology

Article Type

Original Research

Published

21 Jun 2023

In this study, the authors investigated the toxicity and efficacy of cabozantinib in Chinese patients who progressed on VEGFR TKIs and/or ICIs in real-life clinical practice.

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2– breast cancer treated with CDK4/6 inhibitors and endocrine therapy

Barbara Tagliaferri, Ludovica Mollica, Raffella Palumbo, Claudia Leli, Alberto Malovini, Matteo Terzaghi, Erica Quaquarini, Cristina Teragni, Stefano Maccarone, Andrea Premoli, Federico Sottotetti

Article Type

Original Research

Published

20 Jun 2023

This real-life study investigated the link between clinical complexity and quality of life of patients with HR+/HER2– advanced breast cancer treated with CDK4/6 inhibitors.

The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks

Andrea De Giglio, Biagio Ricciuti, Giulio Metro

Article Type

Editorial

Published

02 May 2023

This Editorial by De Giglio, Ricciuti and Metro introduces the series Treatment of advanced non-small-cell lung cancer: one size does not fit all.